Rolipram inhibits staphylococcal enterotoxin B-mediated induction of the human skin-homing receptor on T lymphocytes

Journal of Investigative Dermatology

Volumn 113, Issue 1, 1999, Pages 82-86

  Santamaria, Luis F ^a   Torres, Rosa ^a   Giménez Arnau, Ana M ^b   Giménez Camarasa, Jose M ^b   Ryder, Hamish ^a   Palacios, Jose M ^a   Beleta, Jorge ^a  

^a Almirall Prodesfarma SA Res Ctr ^*  (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

Cutaneous lymphocyte associated antigen; Cyclic adenosine monophosphate; Interleukin 12; Phosphodiesterase

Indexed keywords

HOMING RECEPTOR; INTERLEUKIN 12; ROLIPRAM; SIGUAZODAN; STAPHYLOCOCCUS ENTEROTOXIN B; ZAPRINAST;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKOCYTE MIGRATION INHIBITION; LYMPHOCYTE HOMING; LYMPHOCYTE SUBPOPULATION; NORMAL HUMAN; PRIORITY JOURNAL; SKIN INFLAMMATION; T LYMPHOCYTE ACTIVATION;

EID: 0032806913     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00639.x     Document Type: Article

References (35)

1. - memory T cells. J Immunol 159:4611-4619, 1997
2. Berlin C, Berg EL, Briskin MJ, et al: Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74:185-193, 1993
3. Bourne HR, Lichtenstein LM, Melmon KL, Henney CS, Weinstein Y, Shearer GM: Modulation of inflammation and immunity by cyclic AMP. Science 174:19-28, 1974
4. Butcher EC, Picker LJ: Lymphocyte homing and homeostasis. Science 272:60-66, 1996
5. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G: Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 184:747-752, 1996
6. Essayan DM, Huang S, Undem BJ, Kagey-Sobotka A, Lichtenstein LM: Modulation of antigen-and mitogen induced proliferative responses of peripheral blood mononuclear cells by nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors. J Immunol 153:3408-3416, 1994
7. Essayan DM, Huang S, Kagey-Sobotka A, Lichtenstein LM: Differential efficacy of lymphocyte- and monocyte-selective pretreatment with a type 4 phosphodiesterase inhibitor on antigen-driven proliferation and cytokine gene expression. J Allergy Clin Immunol 99:28-37, 1997
8. Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS: Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389:978-981, 1997
9. Hamid Q, Nascer T, Minshall EM, Song YL, Boguniewicz M, Leung DYM: In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 98:225-231, 1996
10. Hanifin JM, Chan SC, Cheng JB, Tofte SJ, Henderson WR, Kirby DS, Weiner ES: Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. J Invest Dermatol 107:51-56, 1996
11. Hemmerich S, Butcher EC, Rosen SD: Sulfation-dependent recognition of high endothelial venules (HEV) -ligands by L-selectin and MECA 79, an adhesion-blocking monoclonal antibody. J Exp Med 180:2219-2226, 1994
12. Hernández-Caselles T, Martínez-Esparza M, Lazarowits AI, Aparicio P: Specific regulation of VLA-4 and α4β7 integrin expression on human activated T lymphocytes. J Immunol 156:3668-3677, 1996
13. Jeannin P, Delneste Y, Seveso M, Life P, Bonnefoy J: IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells. J Immunol 156:3159-3165, 1996
14. + T cells migrate through superficial vascular plexus but not through deep vascular plexus endothelium. J Invest Dermatol 108:343-348, 1997
15. Leung DYM: Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 96:302-319, 1995
16. Leung DYM, Walsh P, Giorno R, Norris DA: A potential role for superantigens in the pathogenesis of psoriasis. J Invest Dermatol 100:225-228, 1993
17. Leung DYM, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, Picker LJ: Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med 181:747-753, 1995
18. Ling L, Beshay E, Prud'homme GJ: The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice. Diabetes 47:570-575, 1998
19. Ma X, Astc-Amezaga M, Gri G, et al: Immunoregulatory functions and molecular regulation of IL-12. In: Adorini L (ed.). IL-12. Basel: Karger, 1997, pp 1-22
20. Marrack P, Kappler J: The staphylococcal enterotoxins and their relatives. Science 248:705-710, 1990
21. Moller DR: Inhibition of human interleukin-12 production by pentoxifylline. Immunology 91:197-203, 1997
22. 2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 100:1513-1519, 1997
23. Picker LJ, Michie SA, Rott LS, Butcher EC: A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 136:1053-1068, 1990
24. Picker LJ, Kishimoto TK, Smith CW, Warnock RA, Butcher EC: ELAM-1 is an adhesion molecule for skin-homing T cells. Nature 3349:796-799, 1991
25. Rieser C, Böck G, Kloeker H, Bartsch G, Thurnher M: Prostaglandin E2 and tumor necrosis factor α cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J Exp Med 186:1603-1608, 1997
26. Ross SE, Williams RO, Mason LJ, et al: Suppression of TNF-alpha expression, inhibition ot Th1 activity, and amelioration of collagen-induced arthritis by rolipram. J Immunol 159:6253-6259, 1997
27. Santamaria Babi LF, Moser R, Perez Soler MT, Picker LJ, Blaser K, Hauser C: Migration of skin-homing T cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function-associated antigen-1 (LFA-1). J Immunol 154:1543-1550, 1995a
28. Santamaria Babi LF, Picker LJ, Perez Soler MT, Drzimalla K, Flohr P, Blaser K, Hauser C: Circulating allergen-reactive T cells from patients with atopic dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med 181:1935-1940, 1995b
29. Teraki Y, Picker LJ: Independent regulation of cutaneous lymphocyte-associated antigen expression and cytokine synthesis phenotype during human CD4+ memory T cell differentiation. J Immunol 159:6018-6029. Year
30. + T cells migrate into inflamed skin only if they express ligands for E and P-selectin. J Immunol 161:963-970, 1998
31. Torphy TJ: Phosphodiesterase isozymes. Molecular targets for novel antiasthma agents. Am J Respir Crit Care Med 157:351-370, 1998
32. Torphy TJ, Undem BJ: Phosphodiesterase inhibitors: New opportunities for the treatment of asthma. Thorax 46:512-523, 1991
33. + lymphocytes from atopic dermatitis children contain an increased percentage of cells bearing staphylococcal-related T cell receptor variable segments. Clin Exp Allergy 28:1264-1272, 1998
34. Vezzio N, Sarfati M, Yang LP, Demeure CE, Delespesse G: Human Th2-like cell clones induce IL-12 production by dendritic cells and may express several cytokine profiles. Int Immunol 8:1963-1970, 1996
35. Wu C, Wang K, McDyer JF, Seder RA: Prostaglandin E2 and dexamethasone inhibit IL12 receptor expression and IL-12 responsiveness. J Immunol 161:2723-2730, 1998